PP82. PITUICYTOMA: WHEN SHOULD RADIOTHERAPY BE USED?
Dr Aurora Sanz-Torres; United Lincolnshire Hospital Trist PURPOSE: Pituicytoma is an exceptionally rare primary nonadenomatous pituitary gland tumour arising in the neurohypophysis. Since astroglial pituitary tumours are rare and manifestations non-specific, diagnosis is usually achieved after excision. Its treatment remains uncertain and the question for the necessity of adjuvant radiotherapy remains unsettled. The aim of this poster is to report a case who underwent radiotherapy treatment upon tumour relapse and review all the available literature. METHODS: We report a case of a 68-year-old diagnosed with pituicytoma who received radiotherapy treatment upon tumour re-growth ( Figure 1 ) and present a systematic review of the 41 papers obtained by a Medline search using the term "pituicytoma". RESULTS: To date, 51 out of 77 reported cases of pituicytoma (table 1) were followed after surgery (median of 18 months, 3-132 months). Of 25 patients who underwent total resection, only 2 recurred. Whereas 9 of the 24 patients whose tumors were debulked showed tumour progression. Although subtotal resection is accepted as a prognostic factor, only 2 of them received adjuvant radiotherapy. The 12 patients who had documented progression were adults with a prevalence of male gender, trans-sphenoidal approach and subtotal resection. Re-resection was attempted in 7 cases, 5 received radiotherapy (one after re-operation) and 1 remains under surveillance. Follow up data after regrowth is only available for 8 of them, revealing no further progression at a median of 12 months. CONCLUSION: The role of radiotherapy remains unclear, although it seem to be effective for recurrent tumours. The therapy of choice is gross total surgical resection since subtotal removal can lead to local regrowth.
PP83. AN INVESTIGATION INTO THE EVOLUTION OF RACIALLY BIASED DISEASES-GLIOMA, USING A DROSOPHILA MODEL
Mr Ben Treadwell, Mr Peter Abel, Prof Jaipaul Singh; University of Central Lancashire Glioma is a major form of brain cancer throughout the world and studies have shown that the cases and survival rates of brain cancer differ depending on a person's race. The only major genetic difference between races is a small amount of DNA bases; single nucleotide polymorphisms (SNP). This is due to little within-species genomic diversity. A predisposition to glioma is neurofibromatosis type 2 (NF2) shown as tumour growth along the spine and brain stem. NF2 encodes one protein, merlin. Merlin has many roles within the cell at both the membrane and nucleus. At the membrane merlin traffics molecules into and out of the cell and regulates many downstream pathways that are associated with cancer development. In the membrane: merlin stabilises the genome, has an impact in cell-cycle regulation and has an influence. Therefore a change in merlin's function alters the cell, producing many hallmarks of cancer. Glioma and NF2 are both familial, inherited diseases that can pass down and be passed down from parent to offspring. Much research on merlin studies the mutations and potential epigenetic causes of merlin deregulation. Despite this, no study has focused on the inheritance of merlin in relation to its inheritance pattern i.e. Mendelian inheritance. By studying merlin, one can better understand cancer development. Thus by studying the inheritance pattern on merlin, one can deduce the inheritance of familial cancer and the racial bias of brain cancer, confirming merlin's genetic or epigenetic origin. NF2 is an autosomal-dominant condition, however the inheritance pattern of brain tumour may not correlate to this. So by studying the inheritance pattern of merlin in a human model and studying the DNA methylation of the gene NF2; this could answer the current argument of whether mutant merlin or merlin's expression patterns cause the phenotype of NF2 and glioma, evidence is available for both. Recent publications have shown that merlin may be a useful biomarker in glioma therapeutics. The aim of this research is to study the inheritance pattern of merlin in human races using a Drosophila model. Firstly, the aim is to examine the inheritance pattern of merlin in Drosophila. Secondly, to examine the inheritance pattern to deduce whether the inheritance/gene mutation is responsible for NF2 or whether epigenetics is the main cause. Studying the inheritance pattern would aid a conclusion of whether mutations of merlin or epigenetic changes to merlin lead to the phenotype of NF2 and glioma. OBJECTIVE: Pilocytic astrocytomas are extremely rare in octagenarians especially those occurring in the third ventricle. They are similar histopathologically to pilomyxoid astrocytomas but the latter are more aggressive. We report the case of an 86-year old patient presenting with confusion and lethargy secondary to a third ventricular lesion causing obstructive hydrocephalus. The lesion was approached endoscopically and sub-totally resected. Histologically the lesion was classified as a pilocytic astrocytoma with pilomyxoid features. The patient made a full recovery and did not require a shunt. MATERIALS AND METHODS: Case report with pictures and video of the operative approach as well as discussion of the imaging sequences and histology, and review of the literature. RESULTS: Sub-total resection of the tumour was achieved using a monoportal image-guided endoscopic approach. Normal cerebrospinal fluid circulation was restored and a shunt was not required. Histologically, the mass was confirmed to be a pilocytic astrocytoma with pilomyxoid features. The patient made a full recovery with resolution of her symptoms. No such case has been reported in the literature to date. CONCLUSION: This is the first report of a third-ventricular pilocytic astrocytomas with pilomyxoid features in an octogenarian. The endoscopic approach in the case at hand, allowed safe direct visualisation and sub-total resection of the lesion, providing histological diagnosis to guide management and obviating the need for a shunt. The minimally invasive nature of the approach translated into full recovery, despite the age of the patient.
PP84. ENDOSCOPIC RESECTION OF A THIRD VENTRICULAR PILOCYTIC ASTROCYTOMA WITH PILOMYXOID FEATURES IN AN 86-YEAR OLD PATIENT: CASE REPORT AND REVIEW OF THE LITERATURE

PP85. CAVERNOMA AS A BENIGN VASCULAR MALFORMTION: IS IT TIME FOR A RETHINK?
Mr Giannis Sokratous, Mr Ismail Ughratdar, Mr Richard Selway, Prof Safa Al-Sarraj, Prof Keyoumars Ashkan; King's College Hospital NHS Foundation Trust INTRODUCTION: Rapid growth in cerebral cavernous malformation is rare. We present the case of a 71 year old patient with known multiple cavernomas over many years in whom one lesion showed rapid expansion in size. Histological examination revealed co-existence of glioblastoma within the cavernoma. We review the literature for similar cases and discuss the potential mechanisms underlying this transformation. METHODS: Review of the literature though databases MEDLINE, EMBASE, PubMed and Google scholar was performed using keywords glioma, cavernoma and collision tumour. RESULTS: Three cases were identified in the literature with Downloaded from https://academic.oup.com/neuro-oncology/article-abstract/19/suppl_1/i22/3059818 by guest on 20 September 2019
